Concepedia

Bart Jacobs

BJ

32

Publications

1.9K

Citations

19

H-Index

1998

Active since

Affiliations

The Netherlands Cancer Institute(Current)

Utrecht University

Oncode Institute

KU Leuven

Radboud University Nijmegen

Bart Jacobs is an author at The Netherlands Cancer Institute specializing in medicine, pathology, and oncology.

ORCID

Top concepts

Publications per year

1998–2023

32

Publications

32

Amphiregulin and Epiregulin mRNA Expression in Primary Tumors Predicts Outcome in Metastatic Colorectal Cancer Treated With Cetuximab

Bart Jacobs, Wendy De Roock, Hubert Piessevaux et al. · Journal of Clinical Oncology · 2009 · 366 citations · Full text

PIK3CA Mutations Are Not a Major Determinant of Resistance to the Epidermal Growth Factor Receptor Inhibitor Cetuximab in Metastatic Colorectal Cancer

Hans Prenen, Jef De Schutter, Bart Jacobs et al. · Clinical Cancer Research · 2009 · 293 citations · Full text

KRAS gene amplification in colorectal cancer and impact on response to EGFR‐targeted therapy

Emanuele Valtorta, Sandra Misale, Andrea Sartore‐Bianchi et al. · International Journal of Cancer · 2013 · 176 citations · Full text

Quantitative assessment of BRAF V600 mutant circulating cell-free tumor DNA as a tool for therapeutic monitoring in metastatic melanoma patients treated with BRAF/MEK inhibitors

Max Schreuer, Geert Meersseman, Sari Van Den Herrewegen et al. · Journal of Translational Medicine · 2016 · 136 citations · Full text

Pretreatment serum uracil concentration as a predictor of severe and fatal fluoropyrimidine-associated toxicity

Didier Meulendijks, Linda M. Henricks, Bart Jacobs et al. · British Journal of Cancer · 2017 · 119 citations · Full text

Rows per page

1–5 of 32